Loading clinical trials...
Loading clinical trials...
A Phase 1b/2a Study of ABT-888 in Combination With Bendamustine +/- Rituximab in Lymphoma, Multiple Myeloma and Solid Tumors
Conditions
Interventions
Bendamustine Hydrochloride
Pharmacological Study
+2 more
Locations
1
United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Start Date
July 1, 2011
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
December 16, 2019
NCT02997761
NCT00336063
NCT01217411
NCT03493451
NCT02054741
NCT02168140
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions